Short dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk patients: Systematic review and meta-analysis

Short dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk patients: Systematic review and meta-analysis

<h4>Introduction</h4> Dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI) reduces major adverse cardiovascular events (MACE) and stent thrombosis. However, DAPT duration is a concern in high bleeding risk (HBR) patients. We evaluated the effect of short DA...

Full description

Bibliographic Details
Main Authors: Kevin R. Bainey, Guillaume Marquis-Gravel, Blair J. MacDonald, David Bewick, Andrew Yan, Ricky D. Turgeon
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473507/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473507/?tool=EBI

Similar Items